Preparing polymer-based sustained-release systems without exposing proteins to water-oil or water-air interfaces and cross-linking reagents

被引:55
作者
Jin, Tuo [1 ,2 ]
Zhu, Hahao [2 ]
Wu, Fei [1 ]
Yuan, Weien [1 ]
Geng, Lee L.
Zhu, Hua [3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China
[2] Long Isl Univ, Arnold & Marie Schwartz Coll Pharm & Hlth Sci, Long Isl City, NY 11548 USA
[3] UMDNJ, New Jersey Med Sch, Dept Microbiol & Mol Genet, Piscataway, NJ 08854 USA
基金
中国国家自然科学基金;
关键词
protein; sustained-release; stability; PLG/PLA; microspheres; stent;
D O I
10.1016/j.jconrel.2008.02.010
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We report a method to load proteins into polymer-based sustained-release systems without exposing them to water-oil or water-air interfaces, factors known to denature proteins. By dispersing a dextan solution containing a protein into a PEG solution containing small amount of alginate, a stable aqueous-aqueous "emulsion" was formed. The poly-anionic alginate generated a diffuse double layer around each dextran droplet to prevent them from contacting with each other and fusing to a block phase. Proteins distributed in the stabilized dextran droplets by preferential partition favoring dextran. Freeze-drying this emulsion resulted in protein-loaded dextran particles, 1-2 mu m in diameter and 1.6 g/cm(3) in density. The particles were harvested by washing the lyophilized powder using organic solvents to remove the PEG continuous phase. An activity assay of encapsulated P-galactosidase indicated that protein activity was preserved during the particle-forming process including the step of sonicating the particles in organic solvents. The dextran particles also improved release profile and integrity of proteins when encapsulated in degradable polymer sustained-release systems. The aqueous-aqueous emulsion offers a convenient way to prepare solvent-resistant protein-polysaccharide particles that can easily be incorporated in a variety of polymer-based pharmaceutical dosage forms and medical devices such as microspheres, scaffolds and drug-eluting stents for sustained-release protein delivery. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:50 / 59
页数:10
相关论文
共 29 条
[1]   Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics [J].
Bittner, B ;
Morlock, M ;
Koll, H ;
Winter, G ;
Kissel, T .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (03) :295-305
[2]   Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres [J].
Cleland, JL ;
Jones, AJS .
PHARMACEUTICAL RESEARCH, 1996, 13 (10) :1464-1475
[3]  
DIRK H, 2004, CIRCULATION, V110, P36
[4]  
FRANKS F, 1992, STABILITY STABILIZAT, P45
[5]   Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres [J].
Fu, K ;
Pack, DW ;
Klibanov, AM ;
Langer, R .
PHARMACEUTICAL RESEARCH, 2000, 17 (01) :100-106
[6]   QUALITY IMPROVEMENT OF SPRAY-DRIED, PROTEIN-LOADED D,L-PLA MICROSPHERES BY APPROPRIATE POLYMER-SOLVENT SELECTION [J].
GANDER, B ;
WEHRLI, E ;
ALDER, R ;
MERKLE, HP .
JOURNAL OF MICROENCAPSULATION, 1995, 12 (01) :83-97
[7]   Effects of phase separating systems on lyophilized hemoglobin [J].
Heller, MC ;
Carpenter, JF ;
Randolph, TW .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (12) :1358-1362
[8]  
HENNINK WE, 1998, Patent No. 9822093
[9]   Effects of types of sugar on the stabilization of protein in the dried state [J].
Imamura, K ;
Ogawa, T ;
Sakiyama, T ;
Nakanishi, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (02) :266-274
[10]   BETA-GALACTOSIDASE OF STREPTOCOCCUS-CREMORIS H [J].
JAGOTA, SK ;
RAO, MVR ;
DUTTA, SM .
JOURNAL OF FOOD SCIENCE, 1981, 46 (01) :161-&